Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Return on Sales: 2017-2025

Historic Return on Sales for Organogenesis Holdings (ORGO) over the last 8 years, with Sep 2025 value amounting to -0.02%.

  • Organogenesis Holdings' Return on Sales changed negligibly% to -0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.02%, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of -0.02% for FY2024, which is 3.00% down from last year.
  • Latest data reveals that Organogenesis Holdings reported Return on Sales of -0.02% as of Q3 2025, which was up 52.67% from -0.04% recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Return on Sales registered a high of 0.20% during Q4 2021, and its lowest value of -0.06% during Q1 2025.
  • Over the past 3 years, Organogenesis Holdings' median Return on Sales value was -0.02% (recorded in 2024), while the average stood at -0.01%.
  • Per our database at Business Quant, Organogenesis Holdings' Return on Sales grew by 23bps in 2021 and then declined by 17bps in 2022.
  • Organogenesis Holdings' Return on Sales (Quarterly) stood at 0.20% in 2021, then fell by 17bps to 0.03% in 2022, then fell by 2bps to 0.01% in 2023, then dropped by 3bps to -0.02% in 2024, then remained steady at -0.02% in 2025.
  • Its last three reported values are -0.02% in Q3 2025, -0.04% for Q2 2025, and -0.06% during Q1 2025.